Dense tumor‐infiltrating lymphocytes (TILs) in liver metastasis from colorectal cancer are related to improved overall survival
Journal of Surgical Oncology · 2024
DOI: 10.1002/jso.27759 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Surgical Oncology, 2024. Verfasst von Diego Greatti Vaz da Silva und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Abdominal Surgery, A. C. Camargo Cancer, CenterSão Paulo, Brazil. Hauptthemen laut MEDLINE: Lymphocytes, Tumor-Infiltrating, Colorectal Neoplasms, Liver Neoplasms, Hepatectomy. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 27 Literaturangaben.
Abstract (Originalsprache)
Background and Objectives Tumor‐infiltrating lymphocytes (TILs) represent a host‐tumor interaction, frequently signifying an augmented immunological response. Nonetheless, implications with survival outcomes in patients with colorectal carcinoma liver metastasis (CRLM) warrant rigorous validation. The objective was to demonstrate the association between TILs and survival in patients with CRLM.
Method
In a retrospective evaluation conducted in a single institution, we assessed all patients who underwent hepatectomy due to CRLM between 2014 and 2018. Comprehensive medical documentation reviews were executed. TILs were assessed by a liver pathologist, blinded to the clinical information, in all surgical slides.
Results
This retrospective cohort included 112 patients. Median overall survival (OS) was 58 months and disease‐free survival (DFS) was 12 months for the entire cohort. Comparison between groups showed a median OS of 81 months in the dense TILs group and 40 months in the weak/absent group ( p = 0.001), and DFS was 14 months versus 9 months ( p = 0.041). Multivariable analysis showed that TILs were an independent predictor of OS (HR 1.95; p = 0.031).
Conclusions
Dense TILs are a pivotal prognostic indicator, correlating with enhanced OS. Including TILs information in histopathological evaluations should refine the clinical decision‐making process for this group of patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Abdominal Surgery, A. C. Camargo Cancer, CenterSão Paulo, Brazil.
- Department of Pathology, A. C. Camargo Cancer, CenterSão Paulo, Brazil.
- Department of Clinical Oncology, A. C. Camargo Cancer, CenterSão Paulo, Brazil.
ORCID-Profile: Diego Greatti Vaz da Silva, Heber Salvador de Castro de Ribeiro
Zitieren
APA
Vaz da Silva, D. G., de Ribeiro, H. S. C., Dos Santos, G. O., Lindote, M. V. N., Torres, S. M., Diniz, A. L., de Godoy, A. L., de Farias, I. C., Felismino, T. C., da Costa Junior, W. L., & Coimbra, F. J. F. (2024). Dense tumor‐infiltrating lymphocytes (TILs) in liver metastasis from colorectal cancer are related to improved overall survival. Journal of Surgical Oncology. https://doi.org/10.1002/jso.27759
Vancouver
Vaz da Silva DG, de Ribeiro HSC, Dos Santos GO, Lindote MVN, Torres SM, Diniz AL, et al. Dense tumor‐infiltrating lymphocytes (TILs) in liver metastasis from colorectal cancer are related to improved overall survival. Journal of Surgical Oncology. 2024. doi:10.1002/jso.27759
BibTeX
@article{VazdaSilva2024,
author = {Vaz da Silva, Diego Greatti and de Ribeiro, Heber Salvador de Castro and Dos Santos, Gabriel Oliveira and Lindote, Marcus Vitor Nunes and Torres, Silvio Mello and Diniz, Alessandro Lansdskron and de Godoy, André Luiz and de Farias, Igor Correia and Felismino, Tiago Cordeiro and da Costa Junior, Wilson Luiz and Coimbra, Felipe José Fernández},
title = {Dense tumor‐infiltrating lymphocytes (TILs) in liver metastasis from colorectal cancer are related to improved overall survival},
journal = {Journal of Surgical Oncology},
year = {2024},
doi = {10.1002/jso.27759}
}
EUVIMED